Navigation Links
Progress in the Development of Mechanical Circulatory Support Devices for Children to be Presented at International Heart and Lung Transplant Meeting
Date:4/14/2011

pact ECMO (extracorporeal membrane oxygenator) devices.  

The PumpKIN program builds on the NHLBI Pediatric Circulatory Support Program, which initiated funding for the development of novel circulatory support devices in 2004.  The PumpKIN Program will support the realization of the most promising devices in order to gain FDA approval to begin clinical testing, which is anticipated by 2013.

The four PumpKIN contractors are Harvey S. Borovetz, PhD, University of Pittsburgh; Mark Gartner, PhD, Ension, Inc., Pittsburgh; Bartley P. Griffith, MD, University of Maryland School of Medicine; and Robert Jarvik, MD, Jarvik Heart, Inc., New York.

Dr. Griffith will present an update on his research during today's Mid-Day Symposium 4: Update on Pediatric MCS Therapy.

During Friday afternoon's poster sessions, there will also be an update from Ension, Inc.: "The Ension Pediatric Cardiopulmonary Assist System (pCAS):  Progress and Current Status" (Abstract 651).

According to Dr. Baldwin, the contractors are on schedule and making good progress. He said the miniature pediatric devices are based on the latest technology for VAD and ECMO devices.  Preliminary data to be presented at this meeting, and in other forums, suggest that these devices and technology have great promise to perform well in future pediatric patients, based on work ongoing at the PumpKIN study centers.

For more information on the PumpKIN Program, contact the NHLBI Communications Office at nhlbi_news@nhlbi.nih.gov or visit www.nhlbi.nih.gov.

About ISHLT

The International Society for Heart and Lung Transplantation (ISHLT) is a not-for-profit organization dedicated to the advancement of the science and treatment of end-stage heart and lung diseases.  Established in 1981, the Society now includes more than 2,200 members from more
'/>"/>

SOURCE International Society for Heart & Lung Transplantation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Advanced Life Sciences to Host Conference Call to Update Investors on Progress of Corporate Initiatives on October 1, 2008
2. DuPont Meeting Significant 2008 Milestones in Progressing Advanced Biofuels
3. BioElectronics Announces Significant Progress in Canadian and International Distribution
4. Peregrine Pharmaceuticals Reports Progress in Its Phase II Trial of Bavituximab Plus Docetaxel in Patients With Advanced Breast Cancer
5. MedImmune Presents Data Highlighting its Progressive Inflammatory Disease Portfolio at the 72nd Annual Meeting of the American College of Rheumatology
6. Progress toward new storage media
7. Vical Reports Third Quarter 2008 Financial Results and Continued Progress in Product Development Programs
8. Genomic Health Announces Third Quarter 2008 Financial Results and Business Progress
9. New Generation Biofuels Announces Test Burn Agreement With Progress Energy Florida
10. MAP Pharmaceuticals Provides Update on Progress of Two Phase 3 Clinical Programs
11. Synvista Therapeutics Announces Progress in Phase 2 Clinical Trial Program for Alagebrium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... ... July 30, 2015 , ... Tronics, a designer ... & Marketing Director. , With more than 25 years of experience in ... Tronics’ business development activities worldwide. He brings to the company his strong expertise ...
(Date:7/30/2015)... CA (PRWEB) , ... July 30, 2015 , ... ... successful completion of a field clinical study of its canine osteoarthritis stem cell ... with Aratana Therapeutics (Kansas City, KS) and will be marketed in the US ...
(Date:7/30/2015)...  With over 60,000 customers across the globe, ISN improves the efficiency and effectiveness ... more than 60,000 safe and reliable contractors in over 80 countries. ... ... Over 60,000 Worldwide Customers In ... Headquartered in Dallas, TX , ISN has additional ...
(Date:7/30/2015)... July 30, 2015  Discovery Laboratories, Inc. (Nasdaq: ... received the second $1.0M tranche under a previously ... grant valued at up to $3.0 million to ... surfactant as a potential medical countermeasure to mitigate ... was awarded an initial $1.0 million under this ...
Breaking Biology Technology:Tronics appoints Francois Vieillard as Sales and Marketing Director 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 3ISN Reaches Over 60,000 Worldwide Customers 2ISN Reaches Over 60,000 Worldwide Customers 3Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 2Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 3
... ... Ranked Based on Patent Quality, Not Quantity , ... Chicago, IL (PRWeb) January 19, 2010-- Ocean Tomo, LLC, ... performed for Bloomberg BusinessWeek. , , , , ,The study, which ranks the 25 ...
... COLUMBIA, S.C. , Jan. 19 ... University of South Carolina,s Jones Physical Science Center, ... experiments. , The 33,000-square-foot project included the renovation of 11,000 ... Research, which was established in 2002 by the Center for ...
... NANTONG CITY, China , ... "Sinobiopharma" or the "Company"), a fully,integrated and highly innovative biopharmaceutical ... pharmaceutical products,in China , today announced financial results for ... Second Quarter 2010 Highlights, ...
Cached Biology Technology:Ocean Tomo Study Ranks Top 25 Most Inventive Companies for Bloomberg BusinessWeek, 2Ocean Tomo Study Ranks Top 25 Most Inventive Companies for Bloomberg BusinessWeek, 3Ocean Tomo Study Ranks Top 25 Most Inventive Companies for Bloomberg BusinessWeek, 4Hendrick Construction Renovates USC Science Building 2Sinobiopharma Announces Second Quarter 2010 Financial Results 2Sinobiopharma Announces Second Quarter 2010 Financial Results 3Sinobiopharma Announces Second Quarter 2010 Financial Results 4
(Date:7/8/2015)... , July 8, 2015  Trovagene, Inc. ... molecular diagnostics, today announced the launch of a ... Company,s Precision Cancer Monitoring℠ (PCM) technology for predicting ... one or a combination of the novel immunotherapy ... (nivolumab), a PD-1 inhibitor. The 50-patient study will ...
(Date:7/7/2015)... 30, 2015 Research ... addition of the "Capacitive Fingerprint Sensors Patent ... To this date, fingerprint sensing technology is the ... sensors are well developed. This patent landscape focuses ... The domain of capacitive fingerprint sensors is ...
(Date:7/7/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... commerce market announces a revised version of one of its first ... air on CNBC in New York , ... San Francisco metro areas.    ... ability to replace all the cards in your wallet and keep ...
Breaking Biology News(10 mins):Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3
... (January 5, 2011) The Jackson Laboratory (JAX), Sackler School of ... Medicine have unveiled a new mammalian genetics track for PhD ... at both JAX and Tufts. Combining the faculty and resources ... human disease, and the faculty and resources at JAX, with ...
... , Walter and Eliza Hall Institute researchers in Melbourne, ... viruses evade early detection by the immune system. Their ... able to establish chronic infections, leading scientists to reevaluate ... from the institute,s Immunology division together with collaborators at ...
... 5, 2010) The University of Texas Health Science ... first Phase I safety study approved by the Food ... child,s own umbilical cord blood stem cells for traumatic ... in conjunction with Children,s Memorial Hermann Hospital, UTHealth,s primary ...
Cached Biology News:Jackson Laboratory and Tufts University announce new Ph.D. track in mammalian genetics 2Viral evasion gene reveals new targets for eliminating chronic infections 2UTHealth studies cord blood stem cells for pediatric traumatic brain injury 2
Mouse monoclonal antibody raised against a partial recombinant VRK2. NCBI Entrez Gene ID = VRK2...
Mouse monoclonal antibody raised against a partial recombinant L3MBTL2. NCBI Entrez Gene ID = L3MBTL2...
Mouse polyclonal antibody to BAG2 - BCL2-associated athanogene 2...
... a partial recombinant IFNA2. Immunogen: ... is produced in E. coli. The biological ... OMIM: 147562, ... MM951100564 MA Code: ABV0P9DPB ...
Biology Products: